Stocks/Funds/CIK 2081668

Royalty Pharma Sub-Manager, LLC

concentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 2081668
Assets
$173M
Holdings
4
Lifetime alpha vs market
+83.33% annual
Average hold time
0.5 yr
median 0.5 yr

Quarterly history

Cum return +11% vs S&P -4% · α +16% lifetimeAUM $173M · peak $173MFlow $-18M (-10%)2025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
+19.54%
adds into rallies
when a holding rises +10%+

Top positions · 4

Ticker$ value% portYoYHold time
CYTKCytokinetics, Incorporat$65M37.4%0.5 yr
BCAXBicara Therapeutics Inc.$47M27.0%0.5 yr
BCRXBioCryst Pharmaceuticals$37M21.2%0.5 yr
$25M14.4%0.5 yr

Portfolio composition (YoY)

Industry mix
Biotechnology85.6%$148M
Unknown14.4%$25M
Country
US85.6%
Unknown14.4%
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 1

BCAX Bicara Therapeutics Inc. Commo+$22M

Top sells this quarter · 0

No sells this quarter

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$173M4+11.28%-4.37%+15.65%-0.02B
2025-12-31$171M4